These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma. Mocellin S; Del Fiore P; Guarnieri L; Scalerta R; Foletto M; Chiarion V; Pilati P; Nitti D; Lise M; Rossi CR Int J Cancer; 2004 Sep; 111(5):741-5. PubMed ID: 15252844 [TBL] [Abstract][Full Text] [Related]
8. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction. Goydos JS; Ravikumar TS; Germino FJ; Yudd A; Bancila E J Am Coll Surg; 1998 Aug; 187(2):182-8; discussion 188-90. PubMed ID: 9704966 [TBL] [Abstract][Full Text] [Related]
9. Accurate molecular detection of melanoma nodal metastases: an assessment of multimarker assay specificity, sensitivity, and detection rate. Davids V; Kidson SH; Hanekom GS Mol Pathol; 2003 Feb; 56(1):43-51. PubMed ID: 12560463 [TBL] [Abstract][Full Text] [Related]
10. Circulating melanoma cells and distant metastasis-free survival in stage III melanoma patients with or without adjuvant interferon treatment (EORTC 18991 side study). Fusi A; Collette S; Busse A; Suciu S; Rietz A; Santinami M; Kruit WH; Testori A; Punt CJ; Dalgleish AG; Spatz A; Eggermont AM; Keilholz U Eur J Cancer; 2009 Dec; 45(18):3189-97. PubMed ID: 19793643 [TBL] [Abstract][Full Text] [Related]
11. Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay. Włodzimierz R; Rutkowski P; Nowecki ZI; Kulik J; Nasierowska-Guttmejer A; Siedlecki JA Ann Surg Oncol; 2004 Nov; 11(11):988-97. PubMed ID: 15525828 [TBL] [Abstract][Full Text] [Related]
12. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level. Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789 [TBL] [Abstract][Full Text] [Related]
13. Multimarker real-time reverse transcription-PCR for quantitative detection of melanoma-associated antigens: a novel possible staging method. Arenberger P; Arenbergerova M; Gkalpakiotis S; Lippert J; Stribrna J; Kremen J J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):56-64. PubMed ID: 18181974 [TBL] [Abstract][Full Text] [Related]
14. Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA. Hofbauer GF; Dummer R; Laine E; Burg G Arch Dermatol Res; 1998 Aug; 290(8):458-61. PubMed ID: 9763311 [No Abstract] [Full Text] [Related]
15. A metastatic melanoma with an unusual immunophenotypic profile. Gao Z; Stanek A; Chen S Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the use of tyrosinase-specific and melanA/MART-1-specific reverse transcriptase-coupled--polymerase chain reaction to detect melanoma cells in peripheral blood samples from 299 patients with malignant melanoma. Brownbridge GG; Gold J; Edward M; MacKie RM Br J Dermatol; 2001 Feb; 144(2):279-87. PubMed ID: 11251559 [TBL] [Abstract][Full Text] [Related]
17. Detection of melanoma cells in sentinel lymph nodes, bone marrow and peripheral blood by a reverse transcription-polymerase chain reaction assay in patients with primary cutaneous melanoma: association with Breslow's tumour thickness. Blaheta HJ; Paul T; Sotlar K; Maczey E; Schittek B; Paul A; Moehrle M; Breuninger H; Bueltmann B; Rassner G; Garbe C Br J Dermatol; 2001 Aug; 145(2):195-202. PubMed ID: 11531779 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of occult metastases detected by sentinel lymphadenectomy and reverse transcriptase-polymerase chain reaction in early-stage melanoma patients. Bostick PJ; Morton DL; Turner RR; Huynh KT; Wang HJ; Elashoff R; Essner R; Hoon DS J Clin Oncol; 1999 Oct; 17(10):3238-44. PubMed ID: 10506625 [TBL] [Abstract][Full Text] [Related]
19. Detection of tumor-associated circulating mRNA in serum, plasma and blood cells from patients with disseminated malignant melanoma. Hasselmann DO; Rappl G; Rössler M; Ugurel S; Tilgen W; Reinhold U Oncol Rep; 2001; 8(1):115-8. PubMed ID: 11115581 [TBL] [Abstract][Full Text] [Related]
20. Amplification of MelanA messenger RNA in addition to tyrosinase increases sensitivity of melanoma cell detection in peripheral blood and is associated with the clinical stage and prognosis of malignant melanoma. Schittek B; Bodingbauer Y; Ellwanger U; Blaheta HJ; Garbe C Br J Dermatol; 1999 Jul; 141(1):30-6. PubMed ID: 10417512 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]